3
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Characteristics of psychopharmacotherapy in child-psychiatric inpatient treatment in Finland

, &
Pages 105-111 | Accepted 04 Oct 1991, Published online: 12 Jul 2009
 

Abstract

This epidemiologic point-prevalence study explores the prevalence and use of psychopharmacotherapy in child-psychiatric inpatient treatment in Finland. The study was carried out in January 1988. The material consisted of all patients who occupied a child-psychiatric bed on the study day, totaling 237 patients. Most of the child psychiatric inpatients were boys (75%). Adjustment and neurotic-type disorders were the principal reasons for hospitalization. Psychotropic medication was the treatment of choice for 20% of the patients. Regular medication was prescribed for 17% and medication as required for 5%. The prevalence varied considerably between the hospitals (from 0% up to 65%). Medicated children were significantly older than the rest of the patients (11.9 versus 10.1 years). Neuroleptics constituted the most important drug group (63% of all drug prescriptions) and were used in all types of disorders. Psychotic disorders were treated significantly more often with medication (67%) than other types of disturbances. The drug doses used were low compared with suggestions made in child-psychiatric handbooks.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.